J. Kuhn

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
J Kuhn, J. Kuhn, Joachim Kuhn
Publication record
133 papers · 3,878 citations · H-index 32

PAPERS

HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways
20234 citationsauthor #4
Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts
20236 citationsauthor #7
Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
20225 citationsauthor #4
Unravelling the Proteomics of HLA-B*57:01+ Antigen Presenting Cells during Abacavir Medication
20222 citationsauthor #6
Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects
20221 citationsauthor #5
Cytokine-mediated induction of human xylosyltransferase-I in systemic sclerosis skin fibroblasts.
202110 citationsauthor #8
Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
20216 citationsauthor #8
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
202124 citationsauthor #12
Development of a xylosyltransferase-I-selective UPLC MS/MS activity assay using a specific acceptor peptide.
20214 citationsauthor #2
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
202116 citationsauthor #3
Xylosyltransferase-deficient human HEK293 cells show a strongly reduced proliferation capacity and viability.
20204 citationsauthor #5
Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts
202010 citationsauthor #6
Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening
202010 citationsauthor #6
microRNA-145 mediates xylosyltransferase-I induction in myofibroblasts via suppression of transcription factor KLF4.
202010 citationsauthor #7
Point-of-care testing of coagulation in patients treated with edoxaban
202014 citationsauthor #10
Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial
201916 citationsauthor #6
Monitoring of low dabigatran concentrations: diagnostic performance at clinically relevant decision thresholds
20199 citationsauthor #5
First description of a compensatory xylosyltransferase I induction observed after an antifibrotic UDP-treatment of normal human dermal fibroblasts.
20196 citationsauthor #4
The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
201912 citationsauthor #4
Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
201826 citationsauthor #6
microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway
201813 citationsauthor #5
Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: The Effect of Vitamin D on Mortality in Heart Failure Trial
20187 citationsauthor #6
Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
201820 citationsauthor #5
Abstract 98: Point-of-care Testing of Coagulation in Patients Treated With the Non-vitamin K Antagonist Oral Anticoagulant Edoxaban
20180 citationsauthor #8
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
201842 citationsauthor #6
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.
201828 citationsauthor #1
Evaluation of DOAC measurement on the CS-5100 using the INNOVANCE® Heparin and INNOVANCE® DTI reagent
20181 citationsauthor #3
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily
2017168 citationsauthor #6
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
201770 citationsauthor #6
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions
201742 citationsauthor #6
Direct oral anticoagulants and heparins: laboratory values and pitfalls in ‘bridging therapy’
201714 citationsauthor #6
Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring
201711 citationsauthor #6
Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum
201714 citationsauthor #5
Independent Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D with Postoperative Infections in Cardiac Surgical Patients
20160 citationsauthor #2
Abstract 164: Specific Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Part I (SPOCT-NOAC I)
20161 citationsauthor #10
Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device
20167 citationsauthor #5
Measurement of Circulating 1,25-Dihydroxyvitamin D: Comparison of an Automated Method with a Liquid Chromatography Tandem Mass Spectrometry Method
201623 citationsauthor #7
Mapping of amino acid residues controlling fusion activity within the N-terminal part of the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B
20160 citationsauthor #8
Hyperfusogenic mutations in PrV glycoprotein gB - in search of the super-fuser
20160 citationsauthor #3
Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations and Postoperative Infections in Cardiac Surgical Patients: The CALCITOP-Study
201626 citationsauthor #2
Intracellular trafficking of herpes simplex virus type 1 glycoprotein B in syncytial cells
20160 citationsauthor #4
Removal of Dabigatran Is Superior by Sustained Low Efficient Dialysis (SLED) Compared to Intermittent Hemodialysis
20159 citationsauthor #5
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.
201517 citationsauthor #1
Mutational analysis of the cytoplasmic domain of PrV glycoprotein – in search of the super-fuser
20151 citationsauthor #4
25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and postoperative outcome in cardiac surgery.
201535 citationsauthor #2
Association between circulating 25-hydroxyvitamin D levels and medication use in patients scheduled for cardiac surgery.
20156 citationsauthor #2
Human xylosyltransferases – mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy
201543 citationsauthor #7
Point-of-Care Testing of Coagulation in Patients Treated With Non–Vitamin K Antagonist Oral Anticoagulants
201567 citationsauthor #6
Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
20158 citationsauthor #4
Contents Vol. 39, 2015
20150 citationsauthor #64
UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
201539 citationsauthor #1
Plant derived natural products as novel fusion inhibitors against Herpes simplex virus type 1 (HSV-1)
20150 citationsauthor #4
Identification and characterization of human xylosyltransferase II promoter single nucleotide variants.
20150 citationsauthor #5
Independent Association of Circulating Vitamin D Metabolites with Anemia Risk in Patients Scheduled for Cardiac Surgery
201525 citationsauthor #3
Association of 25‐hydroxyvitamin D with anemia risk in patients scheduled for cardiac surgery
201417 citationsauthor #2
A visualizable chain-terminating inhibitor of glycosaminoglycan biosynthesis in developing zebrafish.
201446 citationsauthor #4
First description of the complete human xylosyltransferase-I promoter region
20141 citationsauthor #4
ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?
20141 citationsauthor #2
ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?
201436 citationsauthor #2
Large-Scaled Metabolic Profiling of Human Dermal Fibroblasts Derived from Pseudoxanthoma Elasticum Patients and Healthy Controls
201425 citationsauthor #2
First description of the complete human xylosyltransferase-I promoter region
201411 citationsauthor #4
Measurement of HMG CoA reductase activity in different human cell lines by ultra-performance liquid chromatography tandem mass spectrometry.
20147 citationsauthor #2
Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
201359 citationsauthor #1
Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery.
2013112 citationsauthor #2
The missing “link”: an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation
20130 citationsauthor #12
The missing “link”: an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation
201365 citationsauthor #12
Bioassay-guided fractionation of Eupatorium Perfoliatum L. towards anti-Influenza A-activity leads to dicaffeoyl quinic acids
20121 citationsauthor #5
Vitamin D deficiency is an independent predictor of adverse clinical outcome in cardiac surgery patients
20120 citationsauthor #2
Fast and sample cleanup-free measurement of nicotine and cotinine by stable isotope dilution ultra-performance liquid chromatography-tandem mass spectrometry.
201213 citationsauthor #1
Antiviral effect of polyphenol-enriched extract of Rumex Acetosa L. against Influenza A virus
20120 citationsauthor #4
Front & Back Matter
20120 citationsauthor #64
1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome*
201235 citationsauthor #3
Parameters of Mineral Metabolism predict Midterm Clinical Outcome in End-Stage Heart Failure Patients
201124 citationsauthor #3
Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure
201156 citationsauthor #4
Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans.
201048 citationsauthor #2
Involvement of a cysteine protease in the secretion process of human xylosyltransferase I
201017 citationsauthor #2
Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay.
201028 citationsauthor #1
Proanthocyanidins and ellagitannins: new insights into the use for antiadhesive prophylaxis against viral and microbial pathogens and as skin active compounds
20100 citationsauthor #4
Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
201026 citationsauthor #1
Increased serum xylosyltransferase activity in patients with liver fibrosis.
200918 citationsauthor #1
Calcitriol Deficiency and 1-Year Mortality in Cardiac Transplant Recipients
200956 citationsauthor #5
Determination of beta4-galactosyltransferase-7 activity using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
20093 citationsauthor #1
Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay.
200940 citationsauthor #1
Xylosyltransferase gene variants and their role in essential hypertension.
20094 citationsauthor #4
Antiadhesive natural products for a new cytoprotective strategy against the early stages of infection by pathogens
20090 citationsauthor #6
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.
2009563 citationsauthor #5
High xylosyltransferase activity in children and during mineralization of osteoblast-like SAOS-2 cells
20095 citationsauthor #2
Analysis of xylosyltransferase II binding to the anticoagulant heparin.
20093 citationsauthor #3
Circulating calcitriol concentrations and total mortality.
2009109 citationsauthor #5
Anti-herpes simplex virus type 1 activity of Rhododendron ferrugineum L. extracts
20092 citationsauthor #4
Potent antiviral effect of a polyphenol-enriched Rumex acetosa L. extract against herpes simplex virus type 1 via interaction with viral envelope proteins
20090 citationsauthor #4
First in-gel detection and purification of human xylosyltransferase II.
20092 citationsauthor #3
Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
200823 citationsauthor #4
Poor outcome in end‐stage heart failure patients with low circulating calcitriol levels
2008141 citationsauthor #6
176: Calcitriol Deficiency Is Associated with Increased Mortality Risk in Cardiac Transplant Recipients
20080 citationsauthor #5
Heterologous expression and biochemical characterization of soluble human xylosyltransferase II.
200822 citationsauthor #2
Xylosyltransferase I variants and their impact on abdominal aortic aneurysms.
200812 citationsauthor #7
Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis
200810 citationsauthor #2
Serum xylosyltransferase activity in diabetes mellitus patients as a possible marker of reduced proteoglycan biosynthesis
20081 citationsauthor #2
Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.
200818 citationsauthor #3

TIMELINE

1998 28 citations

1999 86 citations

2000 265 citations

2001 81 citations

2002 52 citations

2003 38 citations

2004 38 citations

2005 119 citations

2006 287 citations

2007 292 citations

2008 227 citations

2009 805 citations

2010 119 citations

2011 80 citations

2012 49 citations

2013 236 citations

2014 144 citations

2015 250 citations

2016 57 citations

2017 319 citations

2018 137 citations

2019 43 citations

2020 48 citations

2021 60 citations

2022 8 citations

2023 10 citations

J. Kuhn

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT